NEW YORK, Dec. 5, 2022 /PRNewswire/ — The HIV treatment drugs market size in Africa is forecast to grow by USD 321.6 million during 2022-2027, at a CAGR of 3.76%. The growth of the market will be driven by the increasing prevalence of STDs. Furthermore, significant demand from awareness campaigns conducted by various organizations is expected to boost the market growth.
Technavio has announced its latest market research report titled Africa HIV Treatment Drugs Market 2023-2027
The report extensively covers the HIV treatment drugs market segmentation in Africa by drug class (reverse transcriptase inhibitors, protease inhibitors, integrase inhibitors, fusion inhibitors, and coreceptor antagonists), route of administration (oral drugs and injectable drugs), and geography (APAC, North America, Europe, Middle East and Africa, and South America). Request A Sample Report
HIV treatment drugs market – Vendors
The growing competition in the market is compelling vendors to adopt various growth strategies such as promotional activities and spending on advertisements to improve the visibility of their services. Some vendors are also adopting inorganic growth strategies such as M&As to remain competitive in the market.
AbbVie Inc.
Alpha Pharma
Aspen Pharmacare Holdings Ltd.
AstraZeneca Plc
Aurobindo Pharma Ltd.
Avacare Health
Boehringer Ingelheim International GmbH
Cipla Ltd.
F. Hoffmann La Roche Ltd.
Gilead Sciences Inc.
GlaxoSmithKline Plc
Hetero Labs Ltd.
Johnson & Johnson
Merck & Co. Inc.
SSI Diagnostica AS
Product Insights and News
AbbVie Inc. – The company offers HIV treatment drugs such as ABBV 1882.
Alpha Pharma – The company offers HIV treatment drugs such as Alpha Cydin.
Aspen Pharmacare Holdings Ltd. – The company offers HIV treatment drugs such as Emdolten.
AstraZeneca Plc – The company offers HIV treatment drugs such as Oxford AstraZeneca vaccine.
Aurobindo Pharma Ltd. – The company offers HIV treatment drugs such as Zidovudine Oral Solution.
For detailed insights about product offerings and the growth strategies adopted by
vendors, buy the report.
Story continues
HIV treatment drugs market – Market Segmentation
The reverse transcriptase inhibitors segment is estimated to contribute significantly to the global market’s growth during the forecast period. Reverse transcriptase inhibitors are pharmaceutical drugs used to treat and manage HIV. They belong to the anti-retroviral class of drugs. Reverse transcriptase inhibitors are further classified into two types, namely nucleoside reverse transcriptase inhibitors (NRTI) and non-nucleoside reverse transcriptase inhibitors (NNRTI). The large-scale availability of NRTIs and NNRTIs for HIV treatment is responsible for the favorable growth of this segment.
The growth of HIV treatment drugs market in Africa is expected to grow further in the reverse transcriptase inhibitors segment with the high use of NNRTI drugs among children and adults and growing R&D activities. – Download a sample report
What are the key data covered in this HIV treatment drugs market in Africa report?
CAGR of the market during the forecast period 2023-2027
Detailed information on factors that will assist the HIV treatment drugs market in Africa growth during the next five years
Estimation of the HIV treatment drugs market in Africa size and its contribution to the parent market
Predictions on upcoming trends and changes in consumer behavior
The growth of the HIV treatment drugs market in Africa
Analysis of the market’s competitive landscape and detailed information on vendors
Comprehensive details of factors that will challenge the growth of the HIV treatment drugs market vendors in Africa
Technavio’s library includes over 17,000+ reports, covering more than 2,000 emerging
technologies. Subscribe to our “Basic Plan” at just USD 5,000 and get lifetime access to
Technavio Insights
Related Reports:
Sexually Transmitted Diseases (STD) Treatment Market by Service and Geography- Forecast and Analysis 2022-2026: The sexually transmitted diseases (STD) treatment market size is forecast to grow by USD 13.48 billion from 2021 to 2026.
Bromhidrosis Disease Treatment Market by Type and Geography – Forecast and Analysis 2022-2026: The bromhidrosis disease treatment market size is forecast to grow to USD 362.76 million from 2021 to 2026.
HIV Treatment Drugs Market In Africa Scope
Report Coverage
Details
Page number
150
Base year
2022
Historic period
2017-2021
Forecast period
2023-2027
Growth momentum & CAGR
Accelerate at a CAGR of 3.76%
Market growth 2023-2027
USD 321.6 million
Market structure
Fragmented
YoY growth 2022-2023(%)
3.5
Regional analysis
Africa
Key countries
South Africa, Nigeria, Kenya, Uganda, and Rest of Africa
Competitive landscape
Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks
Key companies profiled
Abbott Laboratories, AbbVie Inc., Alpha Pharma, Aspen Pharmacare Holdings Ltd., AstraZeneca Plc, Aurobindo Pharma Ltd., Avacare Health, Boehringer Ingelheim International GmbH, Cipla Ltd., F. Hoffmann La Roche Ltd., Gilead Sciences Inc., GlaxoSmithKline Plc, Hetero Labs Ltd.
Market dynamics
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and market condition analysis for the forecast period.
Customization purview
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.
Table of Contents:
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Drug Class
7 Market Segmentation by Route of Administration
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Contact
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com
Africa HIV Treatment Drugs Market 2023-2027
Cision
View original content to download multimedia:https://www.prnewswire.com/news-releases/hiv-treatment-drugs-market-in-africa-growth-opportunities-led-by-abbott-laboratories-and-abbvie-inc—technavio-301692470.html
SOURCE Technavio
Discovered on: 2022-12-05 14:30:00
Source: HIV treatment drugs market in Africa: Growth Opportunities led by Abbott La…
